Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Respiratory syncytial virus: reverse genetics and vaccine strategies.

Collins PL, Murphy BR.

Virology. 2002 May 10;296(2):204-11. Review. No abstract available.

2.

Respiratory syncytial virus vaccines for otitis media.

Anderson LJ.

Vaccine. 2000 Dec 8;19 Suppl 1:S59-65. Review.

PMID:
11163465
3.

Vaccines for neonatal viral infections: towards a live respiratory syncytial virus vaccine:a study in risk.

McIntosh ED, Malinoski FJ, Randolph VB.

Expert Rev Vaccines. 2004 Aug;3(4):353-7. Review.

PMID:
15270633
4.

New vaccines against mucosal pathogens: rotavirus and respiratory syncytial virus.

Coffin SE, Offit PA.

Adv Pediatr Infect Dis. 1997;13:333-48. Review. No abstract available.

PMID:
9544318
5.

Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.

Collins PL, Melero JA.

Virus Res. 2011 Dec;162(1-2):80-99. doi: 10.1016/j.virusres.2011.09.020. Epub 2011 Sep 22. Review.

6.

Carriers for the delivery of a vaccine against respiratory syncytial virus.

Cranage M, Taylor G.

Expert Opin Biol Ther. 2005 Jul;5(7):939-52. Review.

PMID:
16018739
7.

Prospects for a respiratory syncytial virus vaccine.

Hall CB.

Science. 1994 Sep 2;265(5177):1393-4. Review. No abstract available.

PMID:
7915433
8.

Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics.

Murphy BR, Collins PL.

J Clin Invest. 2002 Jul;110(1):21-7. Review. No abstract available.

9.

Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy.

Beeler JA, Eichelberger MC.

Microb Pathog. 2013 Feb;55:9-15. doi: 10.1016/j.micpath.2012.11.013. Epub 2012 Dec 13. Review.

PMID:
23247146
10.
11.

Gene-based vaccine approaches for respiratory syncytial virus.

Loomis RJ, Johnson PR.

Curr Top Microbiol Immunol. 2013;372:307-24. doi: 10.1007/978-3-642-38919-1_15. Review.

PMID:
24362696
12.

Immunization strategies for the prevention of pneumovirus infections.

Bennett N, Ellis J, Bonville C, Rosenberg H, Domachowske J.

Expert Rev Vaccines. 2007 Apr;6(2):169-82. Review.

PMID:
17408367
13.

Preventive and therapeutic strategies for respiratory syncytial virus infection.

Vujovic O, Mills J.

Curr Opin Pharmacol. 2001 Oct;1(5):497-503. Review.

PMID:
11764776
14.

Identifying targets in the hunt for effective respiratory syncytial virus interventions.

Tayyari F, Hegele RG.

Expert Rev Respir Med. 2012 Apr;6(2):215-22. doi: 10.1586/ers.12.8. Review.

PMID:
22455493
15.

Advances in and the potential of vaccines for respiratory syncytial virus.

Jorquera PA, Oakley KE, Tripp RA.

Expert Rev Respir Med. 2013 Aug;7(4):411-27. doi: 10.1586/17476348.2013.814409. Review.

PMID:
23964629
16.

Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.

Castilow EM, Olson MR, Varga SM.

Immunol Res. 2007;39(1-3):225-39. Review.

PMID:
17917067
17.

The non-structural proteins of RSV: targeting interferon antagonists for vaccine development.

Teng MN.

Infect Disord Drug Targets. 2012 Apr;12(2):129-37. Review.

PMID:
22335499
18.

Immunopathology of RSV infection: prospects for developing vaccines without this complication.

van Drunen Littel-van den Hurk S, Mapletoft JW, Arsic N, Kovacs-Nolan J.

Rev Med Virol. 2007 Jan-Feb;17(1):5-34. Review.

PMID:
17004293
19.

[Vaccines against respiratory syncytial virus].

Freymuth F, Vabret A, Gouarin S, Gueudin M, Petitjean J.

Arch Pediatr. 1999;6 Suppl 3:650s-654s. Review. French. No abstract available.

PMID:
10429808
20.
Items per page

Supplemental Content

Write to the Help Desk